HomeNewsBusinessSolar Pharma slips almost 4% after $12 billion Organon deal enters remaining...
Business
Updated:

Solar Pharma slips almost 4% after $12 billion Organon deal enters remaining stage – Moneycontrol.com

Admin
By Admin
The yield on the 10-year Treasury climbed to 4.14% from 4.12%. Getty Images via AFP
The yield on the 10-year Treasury climbed to 4.14% from 4.12%. Getty Images via AFP
- Advertisement -
  1. Solar Pharma slips almost 4% after $12 billion Organon deal enters remaining stage Moneycontrol.com
  2. Solar Pharma closes in on Organon purchase, will get set for $12 billion binding bid The Financial Instances
  3. Solar Pharma shares fall over 3% amid acquisition considerations India At the moment
  4. Defined — Why Solar Pharma shares are down 4% in a robust market CNBC TV18
  5. Solar Pharmaceutical Industries climbs Thursday, underperforms opponents MarketWatch
- Advertisement -
Admin
Adminhttps://nirmalnews.com
Nirmal News - Connecting You to the World
- Advertisement -
Stay Connected
16,985FansLike
36,582FollowersFollow
2,458FollowersFollow
61,453SubscribersSubscribe
Must Read
- Advertisement -
Related News
- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here